Introduction: The Silent Gap in Adolescent Chronic Care

Young adults navigating the transition from adolescence to adulthood face a myriad of physiological and social changes. For those living with chronic illnesses such as epilepsy, congenital heart disease (CHD), or systemic lupus erythematosus (SLE), this period is further complicated by medical complexity. Addressing the SRH needs chronic conditions youth experience is vital because these individuals often fall into a care gap where their primary specialists focus on disease management while neglecting reproductive health. Consequently, many young people remain unaware of how their condition or medications might interact with contraceptive choices or future pregnancy plans. This lack of integrated care leads to significant health disparities, including higher rates of unintended pregnancies and avoidable complications. Recent research efforts are now focusing on mapping these information needs to create more robust, youth-centered health services across North America and beyond.

The Complex Intersection of Epilepsy and Reproductive Choice

Epilepsy presents unique challenges for young adults, particularly concerning the interactions between antiseizure medications (ASMs) and hormonal regulation. Specifically, enzyme-inducing ASMs can significantly reduce the efficacy of hormonal contraceptives by accelerating their metabolism in the liver. This interaction creates a heightened risk of unintended pregnancy, which is especially concerning given the potential teratogenic effects of certain medications like valproate. Moreover, hormonal fluctuations during the menstrual cycle can influence seizure frequency, a phenomenon known as catamenial epilepsy. Despite these critical intersections, many adolescents report that their neurologists rarely initiate conversations about sexual health or family planning. Therefore, there is an urgent requirement to synthesize evidence on how to bridge this communication gap. By identifying the specific informational barriers youth face, clinicians can better provide tailored counseling that accounts for both seizure control and reproductive autonomy. Furthermore, fostering a multidisciplinary approach involving both neurologists and gynecologists is essential for optimizing long-term patient outcomes and safety.

Congenital Heart Disease: Navigating High-Risk Contraception

For young adults born with congenital heart disease, the stakes for sexual and reproductive health are exceptionally high. Pregnancy in this population often carries substantial cardiac risks, including heart failure, arrhythmias, and thromboembolic events. Consequently, effective contraception is not just a matter of lifestyle choice but a critical component of medical management. However, evidence suggests that contraceptive counseling for youth with CHD is often delayed or inconsistently delivered. Many patients remain in the dark about which methods are safest for their specific cardiac anatomy, such as the avoidance of combined oral contraceptives in those with a high risk of stroke or pulmonary hypertension. Additionally, the transition from pediatric to adult cardiology is a vulnerable time when reproductive health discussions frequently disappear from the clinical agenda. Identifying the facilitators that encourage early and frequent SRH discussions can help mitigate these risks. By focusing on youth-centered needs, healthcare systems can ensure that patients with CHD receive the guidance necessary to make informed decisions about their reproductive futures.

Systemic Lupus Erythematosus: Addressing the SRH Needs Chronic Conditions Youth Face

Systemic lupus erythematosus is a multisystem autoimmune disorder that predominantly affects young women during their peak reproductive years. Addressing the SRH needs chronic conditions youth face in the context of SLE is crucial because the disease itself and its treatments, such as mycophenolate mofetil or methotrexate, are highly teratogenic. Patients must often wait for a period of disease quiescence before considering pregnancy to avoid severe complications like pre-eclampsia or preterm birth. Despite these clinical realities, young SLE patients frequently report unmet needs regarding medication safety and fertility preservation. Furthermore, the stigma associated with chronic illness often leads to the de-sexualization of these patients by healthcare providers, resulting in fewer screenings for sexually transmitted infections and less comprehensive contraceptive advice. Therefore, it is imperative to develop strategies that empower youth to advocate for their reproductive health within the rheumatology clinic. Providing clear, accessible information about the timing of pregnancy and the safety of various contraceptive methods can significantly improve the quality of life for these young adults.

Breaking the Barriers to Equitable Healthcare Access

The barriers to accessing sexual and reproductive health information for youth with chronic conditions are multifaceted and occur at various socio-ecological levels. At the individual level, a lack of health literacy and the fear of judgment from providers often prevent young adults from asking vital questions. On an interpersonal level, caregivers may sometimes act as gatekeepers, unintentionally limiting the privacy needed for confidential SRH discussions. Moreover, at the systemic level, the fragmentation of care between pediatric and adult services often results in a loss of continuity. Many specialists feel under-equipped to discuss contraception, while primary care providers may feel hesitant to manage patients with such high medical complexity. To overcome these obstacles, healthcare systems must implement integrated care models that prioritize the patient's voice. This involves training providers in adolescent-friendly communication and ensuring that SRH is a standard part of every chronic disease review. Only by addressing these structural and social barriers can we ensure that all youth, regardless of their medical diagnosis, have equal access to essential health information.

Future Directions: Bridging the Information Gap through Research

The ongoing scoping review protocol aims to provide a comprehensive map of the evidence regarding SRH needs across epilepsy, CHD, and SLE. By synthesizing data from diverse sources, researchers hope to identify common themes and condition-specific nuances that can inform clinical guidelines. Notably, this review will distinguish between the perspectives of youth, caregivers, and providers, ensuring that the final recommendations are truly youth-centered. The synthesis of qualitative and quantitative evidence will allow for a deeper understanding of the barriers that prevent young adults from seeking care. Additionally, mapping these findings across different developmental stages will help clinicians tailor their approach to the specific needs of younger adolescents versus those entering early adulthood. Ultimately, this research serves as a foundation for developing evidence-based interventions that improve health literacy and clinical outcomes. By integrating SRH into the routine management of chronic conditions, the medical community can move toward a more holistic and equitable model of care for the next generation.

Frequently Asked Questions

How do certain chronic disease medications affect the effectiveness of birth control?

Certain medications, particularly enzyme-inducing antiseizure drugs used in epilepsy management, can increase the activity of liver enzymes that break down the hormones found in birth control pills. This process reduces the concentration of these hormones in the bloodstream, making the contraceptive much less effective and increasing the risk of an unintended pregnancy. Patients should consult their specialists to identify non-interacting methods, such as certain intrauterine devices.

Why is reproductive health counseling often neglected in youth with chronic conditions?

Neglect often stems from a combination of provider discomfort, lack of specialized training, and a primary focus on the underlying chronic condition. Many specialists assume that adolescents with severe illnesses are not sexually active, leading to a de-sexualization of the patient. Furthermore, fragmented healthcare systems and a lack of clear protocols for transitioning from pediatric to adult care often result in reproductive health being overlooked during routine consultations.

What are the specific pregnancy risks for young women with systemic lupus erythematosus?

Pregnancy in patients with systemic lupus erythematosus is considered high-risk, especially if the disease is active at the time of conception. Potential complications include increased disease flares, pre-eclampsia, and preterm birth. Moreover, certain medications used to treat lupus can cause severe birth defects. Clinical guidelines generally recommend that patients achieve at least six months of disease remission before attempting to conceive to ensure the best possible outcomes for both mother and child.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Meherali S et al. Sexual and reproductive health information needs of young adults with chronic conditions: a scoping review protocol. Syst Rev. 2026 Jun 26. doi: 10.1186/s13643-026-03253-3. PMID: 42363305.

World Health Organization. Medical eligibility criteria for contraceptive use. Fifth edition. Geneva: World Health Organization; 2015.

Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep 2024.

American Academy of Pediatrics. Contraception for Adolescents: Policy Statement. Pediatrics. 2025;156(1).